ST. PAUL, MN--(Marketwire - October 24, 2007) - GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain and inflammation, is pleased to announce it received a $200,000 purchase order from Icarus Medical Industries Co. for GelStat Migraine. The purchase order is contingent on approval from the Ministry of Health in Kuwait and is the first three expected orders to roll out the product throughout the Middle East.
